Quality of life during and following sequential treatment of previously untreated patients with multiple myeloma: findings of the Medical Research Council Myeloma IX randomised study

In the Medical Research Council (MRC) Myeloma IX trial (ISRCTN684564111) patients were randomised to sodium clodronate or zoledronic acid and induction treatment: cyclophosphamide, vincristine, doxorubicin and dexamethasone (CVAD) or cyclophosphamide, thalidomide and dexamethasone (CTD) followed by...

Descripción completa

Detalles Bibliográficos
Autores principales: Royle, Kara‐Louise, Gregory, Walter M., Cairns, David A., Bell, Sue E., Cook, Gordon, Owen, Roger G., Drayson, Mark T., Davies, Faith E., Jackson, Graham H., Morgan, Gareth J., Child, J. Anthony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Haematological Malignancy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6175065/
https://www.ncbi.nlm.nih.gov/pubmed/29984830
http://dx.doi.org/10.1111/bjh.15459

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6175065/
https://www.ncbi.nlm.nih.gov/pubmed/29984830
http://dx.doi.org/10.1111/bjh.15459

Ejemplares similares